Women Specific Characteristics and 1-Year Outcome Among Patients Hospitalized for Peripheral Artery Disease: A Monocentric Cohort Analysis in a Tertiary Center.
cardiovascular disease
lower extremity arterial disease
peripheral arterial disease
sex differences
vascular surgical procedure
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
29
11
2021
accepted:
17
01
2022
entrez:
24
2
2022
pubmed:
25
2
2022
medline:
25
2
2022
Statut:
epublish
Résumé
Although women have lower age-standardized cardiovascular disease incidence, prevalence, and death-related rates than men, there are also reports indicating that women with cardiovascular disease receive less care, fewer investigations, and have poorer outcomes after a coronary event. The aims of this study were to compare the characteristics of men and women hospitalized for peripheral artery disease (PAD), their cardiovascular and limb outcomes, and their 1-year mortality. The study is a prospective registry collecting data about all consecutive patients hospitalized for PAD within the vascular department of the tertiary center Georges-Pompidou European Hospital (Paris, France). Patients were required to have one of three inclusion criteria: previous revascularization of the lower limb or any lower limb artery occlusion due to an atherosclerotic vascular disease or hemodynamic evidence of PAD. Exclusion criteria were patients with lower extremity arterial occlusion due to another cause. All patients were followed-up for at least 12 months after the initial hospitalization. Among the 235 patients included, there were 61 women (26%), older than men with a median age of 75.6 and 68.3 years, respectively. Main cardiovascular risk factors and comorbidities were similar for men and women except more former or current smokers [145 (83.4%) vs. 33 (54.1%)] and more history of coronary heart disease [42 (24.1%) vs. 7 (11.5%)] in men. Most patients [138 (58.8%)] had critical limb ischemia and 97 (41.3%) had claudication, with no difference for sex. After discharge, 218 patients received an antithrombotic therapy (93.2%), 195 a lipid-lowering drug (83.3%), 185 an angiotensin converting enzyme inhibitor or angiotensin-receptor blocker (78.9%), similarly between sex. At 1-year, overall mortality, major adverse cardiovascular events, major adverse limb events did not differ with 23 (13.2%), 11 (6.3%) and 32 (18.4%) in men, and 8 (13.1%), 3 (4.9%), 15 (24.6%) in women, respectively, despite the difference in age. Overall mortality, cardiovascular outcomes, limb revascularization or amputation did not differ between men and women, 1-year after hospitalization for PAD although the latter were older, less smoker and had less coronary artery disease. Due to the small size of this cohort, larger studies and future research are needed to better understand sex-specific mechanisms in the pathophysiology and natural history of PAD.
Identifiants
pubmed: 35198617
doi: 10.3389/fcvm.2022.824466
pmc: PMC8858944
doi:
Types de publication
Journal Article
Langues
eng
Pagination
824466Informations de copyright
Copyright © 2022 Détriché, Guédon, Mohamedi, Sellami, Cheng, Galloula, Goudot, Khider, Mortelette, Sitruk, Gendron, Sapoval, Julia, Smadja, Mirault and Messas.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Vasa. 2017 Jul;46(4):296-303
pubmed: 28448207
Cardiovasc Diagn Ther. 2019 Feb;9(1):18-29
pubmed: 30881873
J Vasc Surg. 2007 Jun;45(6):1185-91
pubmed: 17543683
Lancet. 2021 Jun 19;397(10292):2385-2438
pubmed: 34010613
Arch Intern Med. 2008 Jul 28;168(14):1568-75
pubmed: 18663170
N Engl J Med. 2017 Jan 5;376(1):32-40
pubmed: 27959717
BMJ Glob Health. 2016 Nov 1;1(3):e000080
pubmed: 28588958
Int J Clin Pract. 2009 Jan;63(1):63-70
pubmed: 19125994
Diabetes Care. 2008 May;31(5):887-92
pubmed: 18268064
Nat Rev Cardiol. 2016 Aug;13(8):471-80
pubmed: 27256211
J Vasc Surg. 2012 Jan;55(1):98-104
pubmed: 22112554
Eur Heart J. 2018 Mar 1;39(9):763-816
pubmed: 28886620
J Vasc Surg. 2006 Aug;44(2):314-8
pubmed: 16890860
Eur J Vasc Endovasc Surg. 2014 Aug;48(2):202-7
pubmed: 24935912
JAMA. 2008 Jul 9;300(2):197-208
pubmed: 18612117
Circulation. 2012 Mar 20;125(11):1449-72
pubmed: 22343782
Menopause. 2012 Jan;19(1):10-5
pubmed: 21900851
Eur Heart J. 2006 Jul;27(14):1743-9
pubmed: 16782720
Eur J Vasc Endovasc Surg. 2013 May;45(5):488-96
pubmed: 23434110
J Vasc Surg. 2007 May;45(5):936-43
pubmed: 17360142
Nat Rev Cardiol. 2017 Mar;14(3):156-170
pubmed: 27853158
Horm Behav. 2019 May;111:87-95
pubmed: 30713101
Circulation. 2017 Mar 21;135(12):e686-e725
pubmed: 27840332
Ann Intern Med. 1976 Oct;85(4):447-52
pubmed: 970770
J Vasc Surg. 2007 Dec;46(6):1295-302
pubmed: 17950570
Clin Obstet Gynecol. 1998 Dec;41(4):912-20
pubmed: 9917946
BMJ Glob Health. 2017 Mar 27;2(2):e000298
pubmed: 28589033
J Vasc Surg. 2009 Dec;50(6):1340-7
pubmed: 19837528
Trends Endocrinol Metab. 2018 Aug;29(8):571-580
pubmed: 29983231
Vasc Endovascular Surg. 2004 Nov-Dec;38(6):547-56
pubmed: 15592636
J Am Coll Cardiol. 2014 Jun 17;63(23):2525-2530
pubmed: 24747101
BMC Public Health. 2010 Jan 27;10:38
pubmed: 20529387
Can J Cardiol. 2018 Apr;34(4):356-361
pubmed: 29571419
Can J Public Health. 2010 Jan-Feb;101(1):96-100
pubmed: 20364548
Circ Res. 2015 Apr 24;116(9):1509-26
pubmed: 25908725
Lancet. 2020 Jul 11;396(10244):97-109
pubmed: 32445693
J Thromb Haemost. 2022 Jan;20(1):230-237
pubmed: 34623025
Eur J Prev Cardiol. 2016 May;23(7):694-703
pubmed: 26385249
Lancet. 2018 Jan 20;391(10117):219-229
pubmed: 29132880
Medicine (Baltimore). 2017 Feb;96(5):e5916
pubmed: 28151868
JAMA. 2007 Mar 21;297(11):1197-206
pubmed: 17374814
Vasa. 2017 Jul;46(4):262-267
pubmed: 28463077
J Am Geriatr Soc. 2003 Feb;51(2):222-8
pubmed: 12558719
Ann Vasc Surg. 1994 Jul;8(4):343-9
pubmed: 7947059
Eur J Vasc Endovasc Surg. 2010 May;39(5):577-85
pubmed: 20303804
JAMA. 2006 Jan 11;295(2):180-9
pubmed: 16403930